European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)
Open accessThe DOI matches its Crossref record; 304 of the 305 references it cites were found in a registry or an index.
Abstract
Endocrine disorders are associated with various tachyarrhythmias, including atrial fibrillation (AF), ventricular tachycardia (VT), ventricular fibrillation (VF), and bradyarrhythmias. Along with underlying arrhythmia substrate, electrolyte disturbances, glucose, and hormone levels, accompanying endocrine disorders contribute to development of arrhythmia. Arrhythmias may be life-threatening, facilitate cardiogenic shock development and increase mortality. The knowledge on the incidence of tachy- and bradyarrhythmias, clinical and prognostic significance as well as their management is limited; it is represented in observational studies and mostly in case reports on management of challenging cases. It should be also emphasized, that the topic is not covered in detail in current guidelines. Therefore, cardiologists and multidisciplinary teams participating in care of such patients do need the evidence-based, or in case of limited evidence expert-opinion based recommendations, how to treat arrhythmias using contemporary approaches, prevent their complications and recurrence in patients with endocrine disorders. In recognizing this close relationship between endocrine disorders and arrhythmias, the European Heart Rhythm Association (EHRA) convened a Task Force, with representation from Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE), with the remit of comprehensively reviewing the available evidence and publishing a joint consensus document on endocrine disorders and cardiac arrhythmias, and providing up-to-date consensus recommendations for use in clinical practice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citationEffects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · Europace · doi:10.1093/europace/euw295 · Cited by 6,439
Self-citationIntensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · Chest · doi:10.1378/chest.10-0134 · Cited by 4,505
Self-citationPriori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Self-citationRoss, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht150 · Cited by 2,809
Self-citationLixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Pfeffer, M. A., Claggett, B., Diaz, R., Dickstein, K., Gerstein, H. C., Køber, L. V., Lawson, F. C., Ping, L., Wei, X., Lewis, E. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509225 · Cited by 2,409
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
Holman, R. R., Bethel, M. A., Mentz, R. J., Thompson, V. P., Lokhnygina, Y., Buse, J. B., Chan, J. C., Choi, J., Gustavson, S. M., Iqbal, N., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612917 · Cited by 2,162
Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033
Acromegaly: An Endocrine Society Clinical Practice Guideline
Katznelson, L., Laws, E. R., Melmed, S., Molitch, M. E., Murad, M. H., Utz, A., & Wass, J. A. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2700 · Cited by 1,786
(2015) · Europace · doi:10.1093/europace/euv319 · Cited by 1,592
Self-citationEvidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
Krahn, A. D., Manfreda, J., Tate, R. B., Mathewson, F. A. L., & Cuddy, T. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80348-9 · Cited by 1,478
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Self-citationSystemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259
Diabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255
Liraglutide and renal outcomes in type 2 diabetes
Mann, J. F. E., Ørsted, D. D., Brown-Frandsen, K., Marso, S. P., Poulter, N. R., Rasmussen, S., Tornøe, K., Zinman, B., & Buse, J. B. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616011 · Cited by 1,253
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr488 · Cited by 1,192
Self-citationAuthors/Task Force Members, Brignole, M., Auricchio, A., Baron-Esquivias, G., Bordachar, P., Boriani, G., Breithardt, O.-A., Cleland, J., Deharo, J.-C., Delgado, V., et al. (2013) · Europace · doi:10.1093/europace/eut206 · Cited by 1,124
Self-citationReduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study
Tsuji, H., Venditti, F. J., Manders, E. S., Evans, J. C., Larson, M. G., Feldman, C. L., & Levy, D. (1994) · Circulation · doi:10.1161/01.cir.90.2.878 · Cited by 1,114
Long-term effects of intensive glucose lowering on cardiovascular outcomes
The ACCORD Study Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1006524 · Cited by 1,035
Hypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
Makkar, R. R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510210076031 · Cited by 971
De Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883
Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W. (2006) · JAMA · doi:10.1001/jama.295.9.1033 · Cited by 862
Malmberg, K., Yusuf, S., Gerstein, H. C., Brown, J., Zhao, F., Hunt, D., Piegas, L., Calvin, J., Keltai, M., Budaj, A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.9.1014 · Cited by 750
Charmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Trends in cardiovascular complications of diabetes
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.292.20.2495 · Cited by 626
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality
Collet, T.-H., Gussekloo, J., Bauer, D. C., den Elzen, W. P. J., Cappola, A. R., Balmer, P., Iervasi, G., Åsvold, B. O., Sgarbi, J. A., Völzke, H., et al. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.402 · Cited by 572
Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
Catena, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.33 · Cited by 565
Huxley, R. R., Filion, K. B., Konety, S., & Alonso, A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.004 · Cited by 561
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration
Freedman, B., Camm, J., Calkins, H., Healey, J. S., Rosenqvist, M., Wang, J., Albert, C. M., Anderson, C. S., Antoniou, S., Benjamin, E. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026693 · Cited by 537
Self-citationMortality in Acromegaly: A Metaanalysis
Dekkers, O. M., Biermasz, N. R., Pereira, A. M., Romijn, J. A., & Vandenbroucke, J. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1191 · Cited by 517
Savard, S., Amar, L., Plouin, P.-F., & Steichen, O. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01060 · Cited by 505
Locati, E. H., Zareba, W., Moss, A. J., Schwartz, P. J., Vincent, G. M., Lehmann, M. H., Towbin, J. A., Priori, S. G., Napolitano, C., Robinson, J. L., et al. (1998) · Circulation · doi:10.1161/01.cir.97.22.2237 · Cited by 493
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2013) · Chest · doi:10.1378/chest.13-0054 · Cited by 482
Self-citationWu, J. H. Y., Foote, C., Blomster, J., Toyama, T., Perkovic, V., Sundström, J., & Neal, B. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00052-8 · Cited by 474
Cherney, D. Z., Perkins, B. A., Soleymanlou, N., Har, R., Fagan, N., Johansen, O., Woerle, H.-J., von Eynatten, M., & Broedl, U. C. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-28 · Cited by 470
8. Pharmacologic Approaches to Glycemic Treatment
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s011 · Cited by 458
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0190 · Cited by 449
Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications
Vassallo, P., & Trohman, R. G. (2007) · JAMA · doi:10.1001/jama.298.11.1312 · Cited by 441
Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study)
Singh, J. P., Larson, M. G., O’Donnell, C. J., Wilson, P. F., Tsuji, H., Lloyd-Jones, D. M., & Levy, D. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00920-6 · Cited by 439
Clinical characteristics of primary aldosteronism from an analysis of 145 cases
Conn, J. W., Knopf, R. F., & Nesbit, R. M. (1964) · The American Journal of Surgery · doi:10.1016/0002-9610(64)90252-1 · Cited by 429
Watanabe, H., Tanabe, N., Watanabe, T., Darbar, D., Roden, D. M., Sasaki, S., & Aizawa, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.744466 · Cited by 427
Adverse Effects of Low Dose Amiodarone: A Meta-Analysis
Vorperian, V. R., Havighurst, T. C., Miller, S., & January, C. T. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00220-9 · Cited by 419
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
Mulatero, P., Monticone, S., Bertello, C., Viola, A., Tizzani, D., Iannaccone, A., Crudo, V., Burrello, J., Milan, A., Rabbia, F., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2805 · Cited by 415
Electrophysiology of Hypokalemia and Hyperkalemia
Weiss, J. N., Qu, Z., & Shivkumar, K. (2017) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004667 · Cited by 404
Chow, E., Bernjak, A., Williams, S., Fawdry, R. A., Hibbert, S., Freeman, J., Sheridan, P. J., & Heller, S. R. (2014) · Diabetes · doi:10.2337/db13-0468 · Cited by 403
Lip, G. Y. H., Freedman, B., De Caterina, R., & Potpara, T. S. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-11-0876 · Cited by 400
Self-citationChamberlain, A. M., Agarwal, S. K., Folsom, A. R., Soliman, E. Z., Chambless, L. E., Crow, R., Ambrose, M., & Alonso, A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.08.049 · Cited by 354
Long QT Syndrome and Pregnancy
Seth, R., Moss, A. J., McNitt, S., Zareba, W., Andrews, M. L., Qi, M., Robinson, J. L., Goldenberg, I., Ackerman, M. J., Benhorin, J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.054 · Cited by 351
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., Dorian, P., Huikuri, H., Kim, Y.-H., Knight, B., et al. (2014) · Europace · doi:10.1093/europace/euu194 · Cited by 327
Self-citationZucchini, S., Scaramuzza, A. E., Bonfanti, R., Buono, P., Cardella, F., Cauvin, V., Cherubini, V., Chiari, G., d’Annunzio, G., Frongia, A. P., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/5719470 · Cited by 326
Selmer, C., Olesen, J. B., Hansen, M. L., Lindhardsen, J., Olsen, A.-M. S., Madsen, J. C., Faber, J., Hansen, P. R., Pedersen, O. D., Torp-Pedersen, C., et al. (2012) · BMJ · doi:10.1136/bmj.e7895 · Cited by 323
Subclinical hyperthyroidism as a risk factor for atrial fibrillation
Auer, J., Scheibner, P., Mische, T., Langsteger, W., Eber, O., & Eber, B. (2001) · American Heart Journal · doi:10.1067/mhj.2001.119370 · Cited by 314
Hyperthyroidism and risk of atrial fibrillation or flutter: A population-based study
Frost, L., Vestergaard, P. M., & Mosekilde, L. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.10.013 · Cited by 313
Diabetes mellitus, glycemic control, and risk of atrial fibrillation
Dublin, S., Glazer, N. L., Smith, N. L., Psaty, B. M., Lumley, T., Wiggins, K. L., Page, R. L., & Heckbert, S. R. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1340-y · Cited by 310
Cardiovascular manifestations of phaeochromocytoma
Prejbisz, A., Lenders, J. W. M., Eisenhofer, G., & Januszewicz, A. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834a4ce9 · Cited by 291
Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients
Lie, J. T., & Grossman, S. J. (1980) · American Heart Journal · doi:10.1016/0002-8703(80)90277-x · Cited by 280
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s009 · Cited by 271
Diabetes, glucose level, and risk of sudden cardiac death
Jouven, X., Lemaître, R. N., Rea, T. D., Sotoodehnia, N., Empana, J.-P., & Siscovick, D. S. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi376 · Cited by 264
Born-Frontsberg, E., Reincke, M., Rump, L. C., Hahner, S., Diederich, S., Lorenz, R., Allolio, B., Seufert, J., Schirpenbach, C., Beuschlein, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2116 · Cited by 261
Silversides, C. K., Harris, L., Haberer, K., Sermer, M., Colman, J. M., & Siu, S. C. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.041 · Cited by 255
Mairesse, G. H., Moran, P., Van Gelder, I. C., Elsner, C., Rosenqvist, M., Mant, J., Banerjee, A., Gorenek, B., Brachmann, J., Varma, N., et al. (2017) · EP Europace · doi:10.1093/europace/eux177 · Cited by 250
Self-citationDoes hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial
The ORIGIN Trial Investigators, Mellbin, L. G., Rydén, L., Riddle, M. C., Probstfield, J., Rosenstock, J., Díaz, R., Yusuf, S., & Gerstein, H. C. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht332 · Cited by 247
Du, X., Ninomiya, T., de Galan, B., Abadir, E., Chalmers, J., Pillai, A., Woodward, M., Cooper, M., Harrap, S., Hamet, P., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp055 · Cited by 239
Self-citationClinical Utility of TSH Receptor Antibodies
Barbesino, G., & Tomer, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4309 · Cited by 237
Cardiovascular Protection Using Beta-Blockers
Bangalore, S., Messerli, F. H., Kostis, J. B., & Pepine, C. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.060 · Cited by 233
Association Between Serum Free Thyroxine Concentration and Atrial Fibrillation
Gammage, M. D. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.928 · Cited by 225
Tanenberg, R. J., Newton, C. A., & Drake, A. J. (2010) · Endocrine Practice · doi:10.4158/ep09260.cr · Cited by 225
Cho, E., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02044-2 · Cited by 225
9. Cardiovascular Disease and Risk Management
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s012 · Cited by 223
Cardiovascular Function in Acromegaly
Clayton, R. N. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0009 · Cited by 223
Approach to the Patient with Amiodarone-Induced Thyrotoxicosis
Bogazzi, F., Bartalena, L., & Martino, E. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0180 · Cited by 206
Mercado, M., Gonzalez, B., Vargas, G., Ramirez, C., de los Monteros, A. L. E., Sosa, E., Jervis, P., Roldan, P., Mendoza, V., López-Félix, B., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2670 · Cited by 199
Piccini, J. P., Berger, J. S., & O'Connor, C. M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp100 · Cited by 198
Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1
Lang, F., & Shumilina, E. (2013) · The FASEB Journal · doi:10.1096/fj.12-218230 · Cited by 194
Gaborit, N., Varro, A., Le Bouter, S., Szuts, V., Escande, D., Nattel, S., & Demolombe, S. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.06.005 · Cited by 194
Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation
Nichols, G. A., Reinier, K., & Chugh, S. S. (2009) · Diabetes Care · doi:10.2337/dc09-0939 · Cited by 185
Boriani, G., Savelieva, I., Dan, G.-A., Deharo, J. C., Ferro, C., Israel, C. W., Lane, D. A., La Manna, G., Morton, J., Mitjans, A. M., et al. (2015) · EP Europace · doi:10.1093/europace/euv202 · Cited by 182
Self-citationCardiovascular Events before and after Surgery for Primary Hyperparathyroidism
Vestergaard, P., Mollerup, C. L., Frøkjær, V. G., Christiansen, P., Blichert‐Toft, M., & Mosekilde, L. (2003) · World Journal of Surgery · doi:10.1007/s00268-002-6541-z · Cited by 180
Stroke in thyrotoxicosis with atrial fibrillation.
Petersen, P., & Hansen, J. M. (1988) · Stroke · doi:10.1161/01.str.19.1.15 · Cited by 178
Surawicz, B., & Parikh, S. R. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02492-0 · Cited by 177
Sonesson, C., Johansson, P. A., Johnsson, E., & Gause-Nilsson, I. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0356-y · Cited by 176
Management of atrial fibrillation in the post-thyrotoxic state
Nakazawa, H. K., Sakurai, K., Hamada, N., Momotani, N., & Ito, K. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90850-6 · Cited by 175
Fatemi, O., Yuriditsky, E., Tsioufis, C., Tsachris, D., Morgan, T., Basile, J., Bigger, T., Cushman, W., Goff, D., Soliman, E. Z., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.045 · Cited by 173
Mortality in acromegaly: a 20-year follow-up study
Ritvonen, E., Löyttyniemi, E., Jaatinen, P., Ebeling, T., Moilanen, L., Nuutila, P., Kauppinen-Mäkelin, R., & Schalin-Jäntti, C. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-16-0106 · Cited by 173
High Incidence of Cardiovascular Complications in Pheochromocytoma
Zelinka, T., Petrák, O., Turková, H., Holaj, R., Štrauch, B., Kršek, M., Vránková, A., Musil, Z., Dušková, J., Kubinyi, J., et al. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1306294 · Cited by 166
Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes
Chen, Y.-C., Chen, S.-A., Chen, Y.-J., Chang, M.-S., Chan, P., & Lin, C.-I. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01731-4 · Cited by 166
FORLEO, G. B., MANTICA, M., DE LUCA, L., LEO, R., SANTINI, L., PANIGADA, S., DE SANCTIS, V., PAPPALARDO, A., LAURENZI, F., AVELLA, A., et al. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01275.x · Cited by 165
High-Normal Thyroid Function and Risk of Atrial Fibrillation: The Rotterdam Study
Heeringa, J., Hoogendoorn, E. H., van der Deure, W. M., Hofman, A., Peeters, R. P., Hop, W. C. J., den Heijer, M., Visser, T. J., & Witteman, J. C. M. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.20.2219 · Cited by 161
The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias
Iravanian, S., & Dudley, S. C. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.02.025 · Cited by 161
Pisters, R., Lane, D. A., Marin, F., Camm, A. J., & Lip, G. Y. H. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-1036 · Cited by 159
Self-citationTadros, R., Ton, A., Fiset, C., & Nattel, S. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.03.032 · Cited by 159
Severe Hypoglycemia–Induced Lethal Cardiac Arrhythmias Are Mediated by Sympathoadrenal Activation
Reno, C. M., Daphna-Iken, D., Chen, Y. S., VanderWeele, J., Jethi, K., & Fisher, S. J. (2013) · Diabetes · doi:10.2337/db13-0216 · Cited by 157
Diabetes as a risk factor for sudden death
Balkau, B., Jouven, X., Ducimetière, P., & Eschwège, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04383-4 · Cited by 156
Age at onset and gender of patients with different types of supraventricular tachycardias
Rodriguez, L.-M., de Chillou, C., Schläpfer, J., Metzger, J., Baiyan, X., van den Dool, A., Smeets, J. L. R. M., & Wellens, H. J. J. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90060-c · Cited by 153
Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update
Floriani, C., Gencer, B., Collet, T.-H., & Rodondi, N. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx050 · Cited by 153
Arrhythmia profile in acromegaly
KAHALY, G., OLSHAUSEN, K. V., MOHR-KAHALY, S., ERBEL, R., BOOR, S., BEYER, J., & MEYER, J. (1992) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060047 · Cited by 153
The influence of surgery on the risk of death in patients with primary hyperparathyroidism
Hedbäck, G., Odén, A., & Tisell, L. (1991) · World Journal of Surgery · doi:10.1007/bf01658740 · Cited by 149
Gillis, A. M. (2017) · Circulation · doi:10.1161/circulationaha.116.025312 · Cited by 148
Aksnes, T. A., Schmieder, R. E., Kjeldsen, S. E., Ghani, S., Hua, T. A., & Julius, S. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.10.025 · Cited by 144
Hay, L. C., Wilmshurst, E. G., & Fulcher, G. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503763816427 · Cited by 143
Manger, W. M., & Gifford, R. W. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.01452.x · Cited by 143
Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study
Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066711 · Cited by 142
(2016) · Europace · doi:10.1093/europace/euw242 · Cited by 126
Self-citationCardiovascular and Renal Damage in Primary Aldosteronism: Outcomes After Treatment
Sechi, L. A., Colussi, G., Fabio, A. D., & Catena, C. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.169 · Cited by 122
Ascoli, P., & Cavagnini, F. (2006) · Pituitary · doi:10.1007/s11102-006-0416-5 · Cited by 121
Cell Death in Acromegalic Cardiomyopathy
Frustaci, A., Chimenti, C., Setoguchi, M., Guerra, S., Corsello, S., Crea, F., Leri, A., Kajstura, J., Anversa, P., & Maseri, A. (1999) · Circulation · doi:10.1161/01.cir.99.11.1426 · Cited by 118
Braunschweig, F., Boriani, G., Bauer, A., Hatala, R., Herrmann-Lingen, C., Kautzner, J., Pedersen, S. S., Pehrson, S., Ricci, R., & Schalij, M. J. (2010) · Europace · doi:10.1093/europace/euq316 · Cited by 113
Self-citationLong QT Interval and Ventricular Tachycardia of “Torsade de Pointe” Type in Hypothyroidism
Fredlund, B., & Olsson, S. B. (1983) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1983.tb03724.x · Cited by 112
Cardiovascular complications in patients with pheochromocytoma: A mini-review
Galetta, F., Franzoni, F., Bernini, G. P., Poupak, F., Carpi, A., Cini, G., Tocchini, L., Antonelli, A., & Santoro, G. (2009) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2009.09.014 · Cited by 111
Cardiac arrhythmias and heart rate in hyperthyroidism
Olshausen, K. V., Bischoff, S. C., Kahaly, G. J., Mohr-Kahaly, S., Erbel, R., Beyer, J., & Meyer, J. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90142-2 · Cited by 110
(1986) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068054 · Cited by 110
Long-Term Outcome of Patients with Acromegaly and Congestive Heart Failure
Bihan, H., Espinosa, C., Valdés-Socin, H., Salenave, S., Young, J., Levasseur, S., Assayag, P., Beckers, A. M., & Chanson, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0821 · Cited by 109
Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle.
Rodrigues, E. A., Caruana, M., Lahiri, A., Nabarro, J. D. N., Jacobs, H. S., & Raftery, E. B. (1989) · Heart · doi:10.1136/hrt.62.3.185 · Cited by 109
Type 2 diabetes mellitus and risk of incident atrial fibrillation in women
Schoen, T., Pradhan, A. D., Albert, C. M., & Conen, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.030 · Cited by 106
Both Hypothyroidism and Hyperthyroidism Increase Atrial Fibrillation Inducibility in Rats
Zhang, Y., Dedkov, E. I., Teplitsky, D., Weltman, N. Y., Pol, C. J., Rajagopalan, V., Lee, B., & Gerdes, A. M. (2013) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000502 · Cited by 105
Scirica, B. M., Bhatt, D. L., Braunwald, E., Raz, I., Cavender, M. A., Im, K., Mosenzon, O., Udell, J. A., Hirshberg, B., Pollack, P. S., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.3030 · Cited by 103
Thyroid Function Abnormalities during Amiodarone Therapy for Persistent Atrial Fibrillation
Batcher, E. L., Tang, X. C., Singh, B. N., Singh, S. N., Reda, D. J., & Hershman, J. M. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.04.022 · Cited by 102
Essebag, V., Hadjis, T., Platt, R. W., & Pilote, L. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02709-2 · Cited by 96
Predictors of Mortality in Patients With Cardiovascular Implantable Electronic Device Infections
Habib, A., LE, K. Y., Baddour, L. M., Friedman, P. A., Hayes, D. L., Lohse, C. M., Wilson, W. R., Steckelberg, J. M., & Sohail, M. R. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.11.052 · Cited by 96
Nakazawa, H. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1956 · Cited by 93
Control of Cardiac Repolarization by Phosphoinositide 3-Kinase Signaling to Ion Channels
Ballou, L. M., Lin, R. Z., & Cohen, I. S. (2014) · Circulation Research · doi:10.1161/circresaha.116.303975 · Cited by 92
Diemberger, I., Mazzotti, A., Biffi, M., Massaro, G., Martignani, C., Ziacchi, M., Reggiani, M. L. B., Battistini, P., & Boriani, G. (2013) · Expert Review of Medical Devices · doi:10.1586/17434440.2013.811837 · Cited by 92
Self-citationTse, G., Lai, E. T. H., Tse, V., & Yeo, J. M. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2848759 · Cited by 91
Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients
Ashburner, J. M., Go, A. S., Chang, Y., Fang, M. C., Fredman, L., Applebaum, K. M., & Singer, D. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.080 · Cited by 91
Infected cardiac-implantable electronic devices: prevention, diagnosis, and treatment
Nielsen, J. C., Gerdes, J. C., & Varma, N. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv060 · Cited by 89
Self-citationAnselmino, M., Matta, M., D'ascenzo, F., Pappone, C., Santinelli, V., Bunch, T. J., Neumann, T., Schilling, R. J., Hunter, R. J., Noelker, G., et al. (2015) · Europace · doi:10.1093/europace/euv214 · Cited by 88
Lombardi, G., Colao, A. A. L., Marzullo, P., Biondi, B., Palmieri, E., & Fazio, S. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344070 · Cited by 88
Overvad, T. F., Skjøth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015) · Stroke · doi:10.1161/strokeaha.115.009371 · Cited by 87
Self-citationSecrest, A. M., Becker, D. J., Kelsey, S. F., LaPorte, R. E., & Orchard, T. J. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03154.x · Cited by 87
Acromegaly and the Cardiovascular System
Lombardi, G., Galdiero, M., Auriemma, R. S., Pivonello, R., & Colao, A. (2006) · Neuroendocrinology · doi:10.1159/000095530 · Cited by 85
Balcıoğlu, S., Arslan, U., Türkoğlu, S., Özdemir, M., & Çengel, A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.106 · Cited by 83
Gender disparity in cardiac electrophysiology: Implications for cardiac safety pharmacology
Jonsson, M. K. B., Vos, M. A., Duker, G., Demolombe, S., & van Veen, T. A. B. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.002 · Cited by 81
Self-citationRisk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
Tsujimoto, T., Sugiyama, T., Shapiro, M. F., Noda, M., & Kajio, H. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09259 · Cited by 81
Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study)
Kim, E.-J., Lyass, A., Wang, N., Massaro, J. M., Fox, C. S., Benjamin, E. J., & Magnani, J. W. (2014) · American Heart Journal · doi:10.1016/j.ahj.2013.10.012 · Cited by 80
Emergencies Caused by Pheochromocytoma, Neuroblastoma, or Ganglioneuroma
Brouwers, F. M., Eisenhofer, G., Lenders, J. W. M., & Pacák, K. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.09.014 · Cited by 80
Severe Primary Hypothyroidism Manifesting with Torsades De Pointes
Schenck, J. B., Rizvi, A. A., & Lin, T. (2006) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200603000-00008 · Cited by 79
Silva, C. M. D. S., Gottlieb, I., Volschan, I., Kasuki, L., Warszawski, L., Lima, G. A. B., Xavier, S. S., Pedrosa, R. C., Neto, L. V., & Gadelha, M. R. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2675 · Cited by 75
Prognostic value of QT interval parameters in type 2 diabetes mellitus
Cardoso, C. R. L., Salles, G. F., & Deccache, W. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00206-4 · Cited by 74
Acromegalic Heart Disease: Influence of Treatment of the Acromegaly on the Heart
(1987) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068078 · Cited by 74
Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study
Kucharska-Newton, A. M., Couper, D. J., Pankow, J. S., Prineas, R. J., Rea, T. D., Sotoodehnia, N., Chakravarti, A., Folsom, A. R., Siscovick, D. S., & Rosamond, W. D. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0157-9 · Cited by 73
Ahmed, S., Van Gelder, I. C., Wiesfeld, A. C. P., Van Veldhuisen, D. J., & Links, T. P. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04087.x · Cited by 72
Zhang, Y., Dedkov, E. I., Lee, B., Li, Y., Pun, K., & Gerdes, A. M. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.10.003 · Cited by 69
Diabetes mellitus and risk of sudden cardiac death: a systematic review and meta-analysis
Zaccardi, F., Khan, H., & Laukkanen, J. A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.105 · Cited by 69
Use of β-Adrenoceptor Blocking Drugs in Hyperthyroidism
Feely, J., & Peden, N. R. (1984) · Drugs · doi:10.2165/00003495-198427050-00003 · Cited by 67
Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble
Seccia, T. M., Caroccia, B., Adler, G. K., Maiolino, G., Cesari, M., & Rossi, G. P. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08956 · Cited by 66
Aldosterone and cardiovascular disease: the heart of the matter
He, B. J., & Anderson, M. E. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.09.004 · Cited by 65
Growth Deceleration Patterns in Children With Constitutional Short Stature: An Aid to Diagnosis
Horner, J. M., Þórsson, Á. V., & Hintz, R. L. (1978) · PEDIATRICS · doi:10.1542/peds.62.4.529 · Cited by 62
New Perspectives On The Role Of Aldosterone Excess In Cardiovascular Disease
Stowasser, M. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03523.x · Cited by 58
Sistema endocrino y corazón: una revisión
Rhee, S. S., & Pearce, E. N. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2010.10.015 · Cited by 56
The Effect of Thyroid Function on Clinical Outcome in Patients with Heart Failure
Chen, S., Shauer, A., Zwas, D. R., Lotan, C., Keren, A., & Gotsman, I. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.42 · Cited by 55
Özcan, K. S., Osmonov, D., Erdinler, I. C., Altay, S., Yıldırım, E., Türkkan, C., Hasdemir, H., Çakmak, N., Alper, A. T., Satılmış, S., et al. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.05.012 · Cited by 55
Lengyel, C., Virág, L., Kovács, P. P., Kristóf, A., Pacher, P., Kocsis, E., Koltay, Z. M., Nánási, P. P., Tóth, M., Kecskeméti, V., et al. (2007) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01753.x · Cited by 53
Occurrence of ventricular late potentials in patients with active acromegaly
Herrmann, B. L., Bruch, C., Saller, B., Ferdin, S., Dagres, N., Ose, C., Erbel, R. M., & Mann, K. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01319.x · Cited by 53
Electrocardiogram in endocrine and metabolic disorders.
Surawicz, B., & Mangiardi, M. L. (1977) · PubMed · Cited by 52
Dysrhythmias and Sudden Death in Acromegalic Heart Disease
Rossi, L., Thiene, G., Caregaro, L., Giordano, R., & Lauro, S. (1977) · CHEST Journal · doi:10.1378/chest.72.4.495 · Cited by 51
Diabetes, glucose tolerance, and the risk of sudden cardiac death
Eranti, A., Kerola, T. V., Aro, A. L., Tikkanen, J. T., Rissanen, H. A., Anttonen, O. M., Junttila, J. M., Knekt, P., & Huikuri, H. V. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0231-5 · Cited by 51
Curtis, A. B., & Narasimha, D. (2012) · Clinical Cardiology · doi:10.1002/clc.21975 · Cited by 50
Diemberger, I., Biffi, M., Martignani, C., & Boriani, G. (2011) · Expert Review of Medical Devices · doi:10.1586/erd.10.80 · Cited by 50
Self-citationJabrocka‐Hybel, A., Bednarczuk, T., Bartalena, L., Pach, D., Ruchała, M., Kamiński, G., Kostecka-Matyja, M., & Hubalewska–Dydejczyk, A. (2015) · Endokrynologia Polska · doi:10.5603/ep.2015.0025 · Cited by 50
Lega, J., Bertoletti, L., Gremillet, C., Chapelle, C., Mismetti, P., Cucherat, M., Vital-Durand, D., Laporte, S., & on behalf of The Meta-Embol Group (2014) · PLoS ONE · doi:10.1371/journal.pone.0091398 · Cited by 49
Late potentials and ventricular arrhythmias in acromegaly
Maffei, P., Martini, C., Milanesi, A., Corfini, A., Mioni, R., Carlo, E. D., Menegazzo, C., Scanarini, M., Vettor, R., Federspil, G., et al. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.12.010 · Cited by 48
Earley, A., Persson, R., Garlitski, A. C., Balk, E. M., & Uhlig, K. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1787 · Cited by 47
Boriani, G., Berti, E., Belotti, L. M. B., Biffi, M., Palma, R. D., Malavasi, V. L., Bottoni, N., Rossi, L. C., Maria, E. D., Mantovan, R., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.509 · Cited by 47
Self-citationHistory of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation
Bruere, H., Fauchier, L., Brunet, A. B., Pierre, B., Siméon, E., Babuty, D., & Clémenty, N. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.07.014 · Cited by 46
Self-citationSiu, C., Jim, M., Zhang, X., Chan, Y., Pong, V., Kwok, J. Y.-Y., Kung, A. W. C., Lau, C., & Tse, H. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.10.019 · Cited by 46
Warszawski, L., Kasuki, L., Sá, R., Silva, C. M. D. S., Volschan, I., Gottlieb, I., Pedrosa, R. C., & Gadelha, M. R. (2016) · Pituitary · doi:10.1007/s11102-016-0749-7 · Cited by 45
Treatment Factors That Influence Mortality in Acromegaly
McCabe, J. J., Ayuk, J., & Sherlock, M. (2015) · Neuroendocrinology · doi:10.1159/000375163 · Cited by 43
Hoppe, U. C., Freemantle, N., Cleland, J. G. F., Marijianowski, M., & Erdmann, E. (2007) · Diabetes Care · doi:10.2337/dc06-2035 · Cited by 43
Echouffo-Tcheugui, J. B., Masoudi, F. A., Bao, H., Spatz, E. S., & Fonarow, G. C. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004132 · Cited by 42
Thyrotoxicosis and the cardiovascular system.
Roffi, M., Cattaneo, F., & Brändle, M. (2005) · PubMed · Cited by 41
Cardiovascular Collapse Associated with Beta Blockade in Thyroid Storm
Dalan, R., & Leow, M. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-971065 · Cited by 40
Treatment with GH receptor antagonist in acromegaly: effect on cardiac arrhythmias
Auriemma, R. S., Pivonello, R., Martino, M. C. D., Cudemo, G., Grasso, L. F. S., Galdiero, M., Perone, Y., & Colao, A. A. L. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0596 · Cited by 39
Role of diabetes in heart rhythm disorders
Koektuerk, B., Aksoy, M., Horlitz, M., Bozdag-Turan, I., & Turan, R. G. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i3.45 · Cited by 38
The clinical value of regular thyroid function tests during amiodarone treatment
Benjamens, S., Dullaart, R. P. F., Sluiter, W. J., Rienstra, M., van Gelder, I. C., & Links, T. P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0018 · Cited by 38
Benefit of Anticoagulation Therapy in Hyperthyroidism‐Related Atrial Fibrillation
Chan, P., Hai, J. J., Yeung, C., Lip, G. Y. H., Lam, K. S. L., Tse, H., & Siu, C. (2015) · Clinical Cardiology · doi:10.1002/clc.22427 · Cited by 36
Self-citationCHEN‐SCARABELLI, C., & SCARABELLI, T. M. (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00298.x · Cited by 36
Hypothyroidism as the cause of atrioventricular block in an elderly patient
Schoenmakers, N. A., de Graaff, W. E., & Peters, R. H. J. (2008) · Netherlands Heart Journal · doi:10.1007/bf03086119 · Cited by 35
Pepe, J., Curione, M., Morelli, S., Varrenti, M., Cammarota, C., Cilli, M., Piemonte, S., Cipriani, C., Savoriti, C., Raimo, O., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0293 · Cited by 35
Risk factors for amiodarone‐induced thyroid dysfunction in Japan
Kinoshita, S., Hayashi, T., Wada, K., Yamato, M., Kuwahara, T., Anzai, T., Fujimoto, M., Hosomi, K., & Takada, M. (2016) · Journal of Arrhythmia · doi:10.1016/j.joa.2016.03.008 · Cited by 35
Wongcharoen, W., Lin, Y., Chang, S.-L., Lo, L.-W., Hu, Y.-F., Chung, F., Chong, E., Chao, T.-F., Tuan, T.-C., Chang, Y.-T., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.06.004 · Cited by 33
Lethal arrhythmia and corticosteroid insufficiency
Nishizawa, S., Nakamura, T., Hamaoka, T., Matsumuro, A., Sawada, T., & Matsubara, H. (2009) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2008.12.001 · Cited by 33
Vidal, J. M. M., Gualis, J., Martín, C. E., Martín, E., Otero, J., Castaño, M., & Martínez‐Comendador, J. M. (2015) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-0035-1555753 · Cited by 32
NAKAYAMA, Y., OHNO, M., YONEMURA, S., UOZUMI, H., KOBAYAKAWA, N., FUKUSHIMA, K., TAKEUCHI, H., & AOYAGI, T. (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00284.x · Cited by 32
Bogossian, H., Frommeyer, G., Brachmann, J., Lewalter, T., Hoffmann, E., Kuck, K. H., Andresen, D., Willems, S., Spitzer, S. G., Deneke, T., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.069 · Cited by 32
Self-citationWorku, B., Tortólani, A. J., Gulkarov, I. M., Isom, O. W., & Klein, I. L. (2015) · Journal of Cardiac Surgery · doi:10.1111/jocs.12513 · Cited by 31
Voss, D. M., & Drake, E. H. (1967) · American Heart Journal · doi:10.1016/0002-8703(67)90154-8 · Cited by 31
Research works printed but not linked: 1
- Cracana, 2016, Severe amiodarone-induced bradycardia conceals sick sinus syndrome: case report, Rev Med Chir Soc Med Nat Iasi, 120, 110
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Self-citation2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Self-citationHindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab648 · Cited by 688
Self-citationHyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis
Wiersinga, W. M., Poppe, K. G., & Effraimidis, G. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00005-0 · Cited by 254
Creta, A., Providencia, R. A., Adragão, P., de Asmundis, C., Chun, K. R. J., Chierchia, G., Defaye, P., Schmidt, B., Anselme, F., Finlay, M., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.12.037 · Cited by 69
Metadata
- Authors
- Gorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., Ramirez, J. D., Vos, M. A., Marin, F., ESC Scientific Document Group, Blomstrom-Lundqvist, C., Rinaldi, A., Bongiorni, M. G., Sciaraffia, E., Nielsen, J. C., Lewalter, T., Zhang, S., Gutiérrez, O., & Fuenmayor, A.
- Affiliations
- Eskisehir Osmangazi University, Eskisehir, Turkey
- University of Modena and Reggio Emilia (IT)
- Carol Davila University of Medicine and Pharmacy (RO)
- Université de Tours (FR)
- Hospital Israelita Albert Einstein (BR)
- Renmin Hospital of Wuhan University (CN)
- Adana, Turkey
- University of Birmingham (GB)
- Royal Adelaide Hospital (AU)
- University of Belgrade (RS)
- Clinica CardioVid, Medellín, Antioquia, Colombia
- University Medical Center Utrecht (NL)
- HU Virgen de la Arrixaca, Murcia, Spain
- Uppsala University (SE)
- Department of Medical Science and Cardiology, Uppsala University, Uppsala, Sweden
- St Thomas’ Hospital, London, UK
- Uppsala University Hospital (SE)
- Aarhus University Hospital (DK)
- Fu Wai Hospital (CN)
- Hospital Clinica Bblica, San Jose, Costa Rica
- Universidad de Los Andes (VE)
- ORCID
- Venue
- EP Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-03-16
- Volume
- 20
- Issue
- 6
- Pages
- 895-896
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- OpenAlex
- W2792402543
- Cited by
- 43
- References
- 305
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 8 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 3 · 2018: 2
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- green
- pure.au.dk
- Licence
- Locations
- EP Europace (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- Novo Nordisk Fonden (NNF16OC0018658)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Keywords
- endocrine disorders, cardiac arrhythmias, tachyarrhythmias, bradycardia, atrial fibrillation, ventricular tachycardia, ventricular fibrillation, cardiac device therapy, antiarrhythmic therapy, electrolyte imbalance, consensus recommendations
- MeSH terms
- Arrhythmias, Cardiac, Endocrine System Diseases, Humans, Patient Care Management, Prognosis, Global Health, Comorbidity, Risk Assessment, Evidence-Based Medicine, Stroke, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.